文献速递认知障碍与痴呆

星形胶质细胞在阿尔茨海默病中的作用:病理生理与临床意义

The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications.
PubMed 文献 · Lancet Neurol · 2019-02-19

本文综述星形胶质细胞在阿尔茨海默病中的作用。遗传学研究提示晚发型阿尔茨海默病的大部分风险与主要由胶质细胞表达的基因(如APOE、APOJ、SORL)相关,研究焦点因此从神经元转向胶质细胞与神经炎症。啮齿类模型提示星形胶质细胞直接参与神经炎症与神经退行性过程,但与人星形胶质细胞存在差异,人干细胞来源星形胶质细胞研究及单细胞转录组学为理解其作用及开发生物标志物与靶向治疗提供方向。

要点

  • 晚发型阿尔茨海默病的大部分遗传风险与胶质细胞表达基因相关
  • 啮齿类星形胶质细胞与人类在形态、功能和基因表达上差异明显
  • 人干细胞来源星形胶质细胞与单细胞转录组学是研究关键方向

核心结论

  • 星形胶质细胞的功能改变参与阿尔茨海默病,研究正从神经元转向胶质细胞与神经炎症,并有望带来新生物标志物与药物靶点。

研究设计与样本

  • 综述文章,总结遗传学、啮齿类模型、人干细胞来源星形胶质细胞及单细胞转录组学等研究证据。

主要发现

  • 晚发型阿尔茨海默病(65岁及以上患者)的大部分风险与主要由胶质细胞表达的基因(即APOE、APOJ和SORL)相关。
  • 啮齿类模型提示星形胶质细胞直接参与导致阿尔茨海默病的神经炎症和神经退行性过程。
  • 啮齿类星形胶质细胞在形态、功能和基因表达上与人星形胶质细胞差异明显,可能不足以模拟人类疾病。

临床怎么用

  • 关注星形胶质细胞生物标志物与靶向治疗的早期研发进展,但尚处探索阶段。

局限性

  • 啮齿类模型可能不足以模拟人类疾病,因人鼠星形胶质细胞差异明显。
  • 人死后脑组织单细胞转录组分析仅提供动态现实的快照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Astrocytes, also called astroglia, maintain homoeostasis of the brain by providing trophic and metabolic support to neurons. They recycle neurotransmitters, stimulate synaptogenesis and synaptic neurotransmission, form part of the blood-brain barrier, and regulate regional blood flow. Although astrocytes have been known to display morphological alterations in Alzheimer's disease for more than a century, research has remained neurocentric. Emerging evidence suggests that these morphological changes reflect functional alterations that affect disease. RECENT DEVELOPMENTS: Genetic studies indicate that most of the risk of developing late onset Alzheimer's disease, the most common form of the disease, affecting patients aged 65 years and older, is associated with genes (ie, APOE, APOJ, and SORL) that are mainly expressed by glial cells (ie, astrocytes, microglia, and oligodendrocytes). This insight has moved the focus of research away from neurons and towards glial cells and neuroinflammation. Molecular studies in rodent models suggest a direct contribution of astrocytes to neuroinflammatory and neurodegenerative processes causing Alzheimer's disease; however, these models might insufficiently mimic the human disease, because rodent astrocytes differ considerably in morphology, functionality, and gene expression. In-vivo studies using stem-cell derived human astrocytes are allowing exploration of the human disease and providing insights into the neurotoxic or protective contributions of these cells to the pathogenesis of disease. The first attempts to develop astrocytic biomarkers and targeted therapies are emerging. WHERE NEXT?: Single-cell transcriptomics allows the fate of individual astrocytes to be followed in situ and provides the granularity needed to describe healthy and pathological cellular states at different stages of Alzheimer's disease. Given the differences between human and rodent astroglia, study of human cells in this way will be crucial. Although refined single-cell transcriptomic analyses of human post-mortem brains are important for documentation of pathology, they only provide snapshots of a dynamic reality. Thus, functional work studying human astrocytes generated from stem cells and exposed to pathological conditions in rodent brain or cell culture are needed to understand the role of these cells in the pathogenesis of Alzheimer's disease. These studies will lead to novel biomarkers and hopefully a series of new drug targets to tackle this disease.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Arranz AM, De Strooper B. The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications. Lancet Neurol. 2019. PMID: 30795987. doi:10.1016/S1474-4422(18)30490-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。